Education
About Us
Working with TipRanks
Follow Us
Daniel Chard Insider Profile
4 Followers
Daniel Chard, Pres Global Sales & Operations at Nu Skin, holds 325.94K shares in Medifast (Ticker: MED), holds 48.11K shares in Nu Skin (Ticker: NUS). Most recently, Daniel Chard Bought ― shares of Medifast on Jun 17, 2025 for an estimated value of 5.00K.
Daniel Chard Nu Skin (NUS)Pres Global Sales & Operations
Nu Skin (NUS)
Pres Global Sales & Operations
Ranked #72,875 out of 102,596 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-25.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Daniel Chard holds in companies
Most Profitable Insider Trade
The most profitable trade made by Daniel Chard
Daniel Chard's Trading History
Nu Skin
Jul 08, 2015
Pres Global Sales & Operations
Uninformative Sell
816.73K
$431.07K
Medifast
Jun 17, 2025
Chairman & CEO, Director
Informative Buy
5.00K
$4.93M
List of latest transactions for each holding click on a transaction to see Daniel Chard's performance on stock
You May Also Like
Daniel Chard insider profile FAQ
What is the percentage of profitable transactions made by Daniel Chard?
The percentage of profitable transactions made by Daniel Chard is 0%.
What is the average return per transaction made by Daniel Chard?
The average return per transaction made by Daniel Chard is -25.60%.
What stocks does Daniel Chard hold?
Daniel Chard holds: NUS, MED stocks.
What was Daniel Chard’s latest transaction?
Daniel Chard latest transaction was an Informative Buy of $5.00K.
What was Daniel Chard's most profitable transaction?
Daniel Chard’s most profitable transaction was an Informative Buy of MED stock on June 17, 2025. The return on the trade was -1.80%.
What is Daniel Chard's role in Nu Skin?
Daniel Chard's role in Nu Skin is Pres Global Sales & Operations.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.